Opzelura 1.5% cream Images
Generic Name: ruxolitinib
This medication has been identified as Opzelura 1.5% cream. It is supplied by Incyte Corporation.
Opzelura is used in the treatment of Vitiligo; Atopic Dermatitis and belongs to the drug class topical antineoplastics. Opzelura 1.5% cream is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Opzelura
- Generic Name
- ruxolitinib
- Strength
- 1.5% cream
- Availability
- Prescription only
- Drug Class
- Topical antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Incyte Corporation
- National Drug Code (NDC)
- 50881-0007
More about Opzelura (ruxolitinib topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- FDA approval history
- Drug class: topical antineoplastics
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
